Modification of mesenchymal stem cells for cardiac regeneration

Heesang Song, Byeong Wook Song, Min Ji Cha, In-Geol Choi, Ki Chul Hwang

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Importance of the field: Mesenchymal stem cells (MSCs) have the greatest potential for use in cell-based therapy of human heart diseases, especially in myocardial infarcts. The therapeutic potential of MSCs in myocardial repair is based on the ability of MSCs to directly differentiate into cardiac tissue and on the paracrine actions of factors released from MSCs. However, the major obstacle in the clinical application of MSC-based therapy is the poor viability of the transplanted cells due to harsh microenvironments like ischemia, inflammation and/or anoikis in the infarcted myocardium. Recently, various approaches have been implemented in an effort to improve the survival of implanted MSCs through ex vivo manipulation of MSCs. Areas covered in this review: Major obstacles in MSC-based therapy are discussed, along with recent advances for enhancing therapeutic potential of engrafted MSCs from the past decade. What the reader will gain: This review focuses primarily on ex vivo manipulation of MSCs before transplantation, which includes pretreatment, preconditioning and genetic modification of MSCs, and future directions. Take home message: Modification of MSCs before transplantation has developed into a promising option for enhancing the beneficial effects of MSC-based therapy for cardiac repair after myocardial infarction.

Original languageEnglish
Pages (from-to)309-319
Number of pages11
JournalExpert Opinion on Biological Therapy
Volume10
Issue number3
DOIs
Publication statusPublished - 2010 Mar 1

Fingerprint

Stem cells
Mesenchymal Stromal Cells
Regeneration
Cell- and Tissue-Based Therapy
Mesenchymal Stem Cell Transplantation
Myocardial Infarction
Anoikis
Repair
Heart Diseases
Cell Survival
Myocardium
Ischemia
Inflammation
Tissue
Survival

Keywords

  • Cardiac regenration
  • Cell adhesion
  • Cell survival
  • Mesenchymal stem cell

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry
  • Drug Discovery

Cite this

Modification of mesenchymal stem cells for cardiac regeneration. / Song, Heesang; Song, Byeong Wook; Cha, Min Ji; Choi, In-Geol; Hwang, Ki Chul.

In: Expert Opinion on Biological Therapy, Vol. 10, No. 3, 01.03.2010, p. 309-319.

Research output: Contribution to journalArticle

Song, Heesang ; Song, Byeong Wook ; Cha, Min Ji ; Choi, In-Geol ; Hwang, Ki Chul. / Modification of mesenchymal stem cells for cardiac regeneration. In: Expert Opinion on Biological Therapy. 2010 ; Vol. 10, No. 3. pp. 309-319.
@article{a10a76f02cbd446ea243293c4100a5fc,
title = "Modification of mesenchymal stem cells for cardiac regeneration",
abstract = "Importance of the field: Mesenchymal stem cells (MSCs) have the greatest potential for use in cell-based therapy of human heart diseases, especially in myocardial infarcts. The therapeutic potential of MSCs in myocardial repair is based on the ability of MSCs to directly differentiate into cardiac tissue and on the paracrine actions of factors released from MSCs. However, the major obstacle in the clinical application of MSC-based therapy is the poor viability of the transplanted cells due to harsh microenvironments like ischemia, inflammation and/or anoikis in the infarcted myocardium. Recently, various approaches have been implemented in an effort to improve the survival of implanted MSCs through ex vivo manipulation of MSCs. Areas covered in this review: Major obstacles in MSC-based therapy are discussed, along with recent advances for enhancing therapeutic potential of engrafted MSCs from the past decade. What the reader will gain: This review focuses primarily on ex vivo manipulation of MSCs before transplantation, which includes pretreatment, preconditioning and genetic modification of MSCs, and future directions. Take home message: Modification of MSCs before transplantation has developed into a promising option for enhancing the beneficial effects of MSC-based therapy for cardiac repair after myocardial infarction.",
keywords = "Cardiac regenration, Cell adhesion, Cell survival, Mesenchymal stem cell",
author = "Heesang Song and Song, {Byeong Wook} and Cha, {Min Ji} and In-Geol Choi and Hwang, {Ki Chul}",
year = "2010",
month = "3",
day = "1",
doi = "10.1517/14712590903455997",
language = "English",
volume = "10",
pages = "309--319",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Modification of mesenchymal stem cells for cardiac regeneration

AU - Song, Heesang

AU - Song, Byeong Wook

AU - Cha, Min Ji

AU - Choi, In-Geol

AU - Hwang, Ki Chul

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Importance of the field: Mesenchymal stem cells (MSCs) have the greatest potential for use in cell-based therapy of human heart diseases, especially in myocardial infarcts. The therapeutic potential of MSCs in myocardial repair is based on the ability of MSCs to directly differentiate into cardiac tissue and on the paracrine actions of factors released from MSCs. However, the major obstacle in the clinical application of MSC-based therapy is the poor viability of the transplanted cells due to harsh microenvironments like ischemia, inflammation and/or anoikis in the infarcted myocardium. Recently, various approaches have been implemented in an effort to improve the survival of implanted MSCs through ex vivo manipulation of MSCs. Areas covered in this review: Major obstacles in MSC-based therapy are discussed, along with recent advances for enhancing therapeutic potential of engrafted MSCs from the past decade. What the reader will gain: This review focuses primarily on ex vivo manipulation of MSCs before transplantation, which includes pretreatment, preconditioning and genetic modification of MSCs, and future directions. Take home message: Modification of MSCs before transplantation has developed into a promising option for enhancing the beneficial effects of MSC-based therapy for cardiac repair after myocardial infarction.

AB - Importance of the field: Mesenchymal stem cells (MSCs) have the greatest potential for use in cell-based therapy of human heart diseases, especially in myocardial infarcts. The therapeutic potential of MSCs in myocardial repair is based on the ability of MSCs to directly differentiate into cardiac tissue and on the paracrine actions of factors released from MSCs. However, the major obstacle in the clinical application of MSC-based therapy is the poor viability of the transplanted cells due to harsh microenvironments like ischemia, inflammation and/or anoikis in the infarcted myocardium. Recently, various approaches have been implemented in an effort to improve the survival of implanted MSCs through ex vivo manipulation of MSCs. Areas covered in this review: Major obstacles in MSC-based therapy are discussed, along with recent advances for enhancing therapeutic potential of engrafted MSCs from the past decade. What the reader will gain: This review focuses primarily on ex vivo manipulation of MSCs before transplantation, which includes pretreatment, preconditioning and genetic modification of MSCs, and future directions. Take home message: Modification of MSCs before transplantation has developed into a promising option for enhancing the beneficial effects of MSC-based therapy for cardiac repair after myocardial infarction.

KW - Cardiac regenration

KW - Cell adhesion

KW - Cell survival

KW - Mesenchymal stem cell

UR - http://www.scopus.com/inward/record.url?scp=76949087876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76949087876&partnerID=8YFLogxK

U2 - 10.1517/14712590903455997

DO - 10.1517/14712590903455997

M3 - Article

VL - 10

SP - 309

EP - 319

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 3

ER -